What would an antiviral pill mean for the fight against COVID-19?

admin - October 03, 2021

Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from COVID-19.